Abivax S.A.
NASDAQ:ABVX · NASDAQ Global Market
-$0.62 today
Vol 1.68M · Avg 1.59M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+1522.75%
Period High
$145.31
Period Low
$6.11
Latest
$99.15
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.17B
Axsome Therapeutics, Inc.
NASDAQ:AXSM
$12.94B
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
$11.67B
Cytokinetics, Incorporated
NASDAQ:CYTK
$9.86B
Nuvalent, Inc.
NASDAQ:NUVL
$9.08B
Corcept Therapeutics Incorporated
NASDAQ:CORT
$8.88B
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.08B
Metsera, Inc.
MTSR
$7.43B
Merus N.V.
MRUS
$6.83B
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
$6.81B
What is the latest ABVX filing?
The latest filing shown is 6-K dated Jun 2, 2026.
How many recent filings does ABVX have?
Intrinsic Alpha currently shows 20 recent filings for ABVX.
Explore More
Continue the stock analysis
Jump to another research area for this company.